José Palacios
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Epidemiology top 10%
- Genetics top 10%
- Co-authors
- Gema Moreno‐BuenoHéctor Hernández‐VargasDavid SarrióDavid HardissonMarı́a A. BlascoCristina SánchezManuel GuzmánMaría M. Caffarel
- Topics
- Cancer-related Molecular Pathways (12 papers)HER2/EGFR in Cancer Research (7 papers)Cancer Genomics and Diagnostics (6 papers)
- Cited by
- OncologyCancer ResearchAging
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
José Palacios
56 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 1.5k
- Oncology 870
- Cancer Research 441
- Epidemiology 365
- Genetics 290
Countries citing papers authored by José Palacios
This map shows the geographic impact of José Palacios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Palacios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Palacios more than expected).
Fields of papers citing papers by José Palacios
This network shows the impact of papers produced by José Palacios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Palacios. The network helps show where José Palacios may publish in the future.
Co-authorship network of co-authors of José Palacios
This figure shows the co-authorship network connecting the top 25 collaborators of José Palacios. A scholar is included among the top collaborators of José Palacios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Palacios. José Palacios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 44 | |
| 3 | 57 | |
| 4 | 143 | |
| 5 | 7 | |
| 6 | 70 | |
| 7 | 62 | |
| 8 | 12 | |
| 9 | 61 | |
| 10 | 51 | |
| 11 | 23 | |
| 12 | 215 | |
| 13 | 73 | |
| 14 | 96 | |
| 15 | 89 | |
| 16 | 15 | |
| 17 | 10 | |
| 18 | 3 | |
| 19 | p53 in breast cancer. Its relation to histological grade, lymph-node status, hormone receptors, cell-proliferation fraction (ki-67) and c-erbB-2. Immunohistochemical study of 153 cases. | 27 |
| 20 | 15 |
About José Palacios
José Palacios is a scholar working on Cancer Research, Oncology and Obstetrics and Gynecology, having authored 58 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (12 papers), HER2/EGFR in Cancer Research (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Oncology (870 citations), Cancer Research (441 citations) and Aging (50 citations). José Palacios has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Gema Moreno‐Bueno, Héctor Hernández‐Vargas, David Sarrió, David Hardisson, Marı́a A. Blasco, Cristina Sánchez, Manuel Guzmán, María M. Caffarel, Manuel Serrano and Daniel Herranz. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.